151109 Edanz Kinki
-
Upload
edanz-group -
Category
Education
-
view
312 -
download
8
Transcript of 151109 Edanz Kinki
Effectively Communicating Your Research
Kinki University
9 November 2015
Dr Trevor Lane
Dr Eri Kinoshita
S
Be an effective communicator
Your goal is not only to be published, but also to be widely read and cited
Developing advanced writing skills
Logically communicating your ideas in your manuscript
Making the best first impression
Avoiding common peer reviewer complaints
Succeeding with Edanz
Section 1
Developing advanced writing skills
Coverage and Staffing Plan Writing skills
Where to start?
Your findings form the basis of your manuscript
First organize your findings
Logic, then English language
Figure 1
Figure 2
Table 1
Figure 3
Logical flow • Chronology • Least to most
important • General to
specific • Whole+parts
Is anything missing?
? Additional analyses?
Use your illustrations to structure your manuscript
Coverage and Staffing Plan Writing skills Impact and study design
Systematic
reviews of RCTs
Randomized controlled
trials (RCTs)
Other controlled trials
Observational studies (cohort, case-control,
cross-sectional surveys/audits, diagnostics)
Computer models (in silico), animal models (in vivo),
in vitro, case studies
Case studies, anecdote, opinion, technical,
simulation
Hypothesis
testing
{ Descriptive
Methodological {
{
Secondary
research
Primary
research
{ } Experimental (exposure assigned)*
}
} Non-
experimental
*
Coverage and Staffing Plan Writing skills Use reporting guidelines
PRISMA Systematic reviews &
Meta-analyses
STROBE Observational studies
CARE Case reports
CONSORT Randomized controlled
trials
http://www.equator-network.org/
clinicaltrials.gov; who.int/ictrp/network/en; controlled-trials.com; umin.ac.jp/ctr
Coverage and Staffing Plan Writing skills Use reporting guidelines
CONSORT
http://www.equator-network.org/
Coverage and Staffing Plan Writing skills Prepare an outline
I. Introduction A. General background B. Related studies C. Problems in the field D. Aims
II. Methods A. Subjects/Samples/Materials B. General methods C. Specific methods D. Statistical analyses
III. Results A. Key points about Figure 1 B. Key points about Table 1 C. Key points about Figure 2 D. Key points about Figure 3 E. Key points about Figure 4
IV. Discussion A. Major conclusion B. Key findings that support conclusion C. Relevance to published studies D. Limitations E. Unexpected results F. Implications G. Future directions
Write down key ideas in bullet points, as IMRaD
Use reporting guidelines
No need for sentences or correct English yet
Then, draft the title/abstract
List information from your reading in the appropriate section: Paraphrase with citations!
Coverage and Staffing Plan Writing skills Journal Selector
www.edanzediting.co.jp/journal_selector
Insert your proposed abstract/title or keywords
Coverage and Staffing Plan Writing skills
Filter/sort by: • Field of study • Impact factor • Indexed in SCI • Open access • Publishing frequency
Journal Selector www.edanzediting.co.jp/journal_selector
Journal’s aims & scope, IF, and publication frequency
• Author guidelines • Journal website
Similar abstracts
Coverage and Staffing Plan Writing skills Get feedback
Write your manuscript section-by-section – Less stressful – Get feedback after each section; set deadlines – Easier for your colleagues to review
Revise for content, overall logic, and journal style (see guidelines/past papers)
Edit for conciseness, clarity, consistency & accuracy
Get feedback from pre-submission peer review
Get language assistance
Coverage and Staffing Plan Writing skills Avoid mistakes 1
Keep it simple!
Use short sentences 15–20 words; one idea per sentence
Prefer simpler/shorter words
Use active voice Simpler, more direct, and easier to read
Most writing style guides and journals prefer it… “Nature journals prefer authors to write in the active voice”
(http://www.nature.com/authors/author_resources/how_write.html)
Coverage and Staffing Plan Writing skills Avoid mistakes 1
Prefer Enough Clear Determine Begin Try Very Size Keep Enough End Use
Avoid Adequate Apparent Ascertain Commence Endeavor Exceedingly Magnitude* Retain Sufficient Terminate* Utilization *OK in certain fields (magnitude of earthquakes, to terminate gene expression)
Coverage and Staffing Plan Writing skills
“A number of studies have shown that the charged group...”
“...as described in our previous study.”
“...at a flow rate of 1.0 mL/min.”
“As a matter of fact, such a low-temperature reaction…”
“That is another reason why, we believe…”
“It is well known that most of the intense diffraction peaks...” “It is well known that Most of the intense diffraction peaks...”
“As a matter of fact, such a This low-temperature reaction…”
“A number of studies have shown that The charged group...”
“That is thus another reason why Therefore, we believe…”
“...as described previously in our previous study.”
“...at a flow rate of 1.0 mL/min.”
Avoid mistakes 2
Delete extra words!
Coverage and Staffing Plan Writing skills
Avoid At a concentration of 2 g/L At a temperature of 37C In order to In the first place Four in number Green color Subsequent to Prior to Future plans; past history
Prefer At 2 g/L At 37C To First Four Green After Before Plans; history
Avoid mistakes 2
Coverage and Staffing Plan Writing skills
Estimate Estimation
Decide Decision
Assess Assessment
We made a/an… We conducted a/an… Extra verb
We decided… Clear, short, and direct
Avoid mistakes 3
Don’t hide verbs inside nouns!
Coverage and Staffing Plan Writing skills
Compared with is for saying how things are different
The toxicity of the new scaffold was reduced
compared to the previous scaffold.
The toxicity of the new scaffold was reduced compared with that of the previous scaffold.
The toxicity of the new scaffold was lower than that of the previous scaffold.
Avoid mistakes 4
Coverage and Staffing Plan Writing skills
Readers expect…
verbs to closely follow their subjects heavy ends (not starts) of clauses
Subject
The viral infection that the patient caught on a trip to an outbreak-prone area in Africa spread among the hospital staff quickly.
The patient caught a viral infection on a trip to an outbreak-prone area in Africa. This infection spread quickly among the hospital staff.
Verb
Avoid mistakes 5
Activity 1
Please see Activity 1 in your workbook
Section 2
Logically communicating your ideas in your manuscript
Manuscripts with impact The ‘write’ order
How does your study contribute to your field?
What did you find?
What did you do?
Why did you do the study?
Title/Abstract
Introduction
Methods
Results
Discussion
Manuscripts with impact
Title/Abstract
Introduction
Methods
Results
Discussion
Title/Abstract
Methods
Results
Discussion
Introduction
Abstract /Title
write
The ‘write’ order
Manuscripts with impact Introduction
Why is your study needed?
Current state of the field
Background information
Specific aim/approach Aim
Problem in the field
Previous studies
Current study
General
Specific Importance/Hypothesis
Worldwide relevance? Broad/specialized?
Up-to-date International
Manuscripts with impact Writing the Introduction
Currently, the standard procedure used to evaluate hepatic steatosis is the histopathological examination of cross-liver sections… …this is an invasive practice that presents inherent risks... Therefore, it is essential to establish new non-invasive approaches to accurately determine hepatic fat concentration…
Aims
The purpose of our prospective study…was to evaluate the potential of multi-echo MRI to quantitate the hepatic triglyceride concentration.
Problem
Jiménez-Agüero et al. BMC Med. 2014; 12:137.
The aims should directly address the problem
Manuscripts with impact
Study design
Methods
http://www.equator-network.org/
Manuscripts with impact
How the study was done
• Processes, treatments, measurements, follow-up
• Variables (direct/proxy) • Outcome/endpoints (1o, 2o)
• Quantification/models • Statistical tests (& P level) • Consult a statistician
Who/what was studied
• Participants, controls • Enrollment, N & “power” • Materials, databases
Data analysis
What did you do?
Methods
Manuscripts with impact Methods
Describe all aspects of the design
Established techniques
• Cite previously published studies • Briefly state modifications
• Enough detail for reproducibility • Use Supplementary Information
Organization • Arrange in subsections • Parallel order with the figures
New techniques
Manuscripts with impact Results
• Efficacy/safety • Group/subgroups • Uni-/bi-/multivariable
• Each subsection corresponds to one figure and method
• What you found, not what it means
• Use Supplementary Information
• Data accessibility
Logical presentation
Subsections
Factual description
What did you find?
Manuscripts with impact
Drug A reduced tumor volume by 32.7%, increased blood pressure by 12.3%, and increased the patient’s weight by 7.3 kg. Drug B reduced tumor volume by 22.3%, increased blood pressure by 15.6%, and increased the patient’s weight by 2.4 kg. Drug C reduced tumor volume by 38.1%, increased blood pressure by 6.9%, and increased the patient’s weight by 9.2 kg.
Describe relationships among your results
Manuscripts with impact
Patients treated with Drug C showed the greatest reduction in tumor volume (28.1%) compared with those treated with Drug A (32.7%) or Drug B (22.3%). Drug C also had the lowest increase in blood pressure (6.9%) compared with that seen after treatment with Drug A (12.3%) or Drug B (15.65). However, patients treated with Drug C had the highest weight gain among the three groups (Drug A, 7.3 kg; Drug B, 2.4 kg; Drug C, 9.2 kg).
Describe relationships among your results
Manuscripts with impact Discussion
Summary of findings
Relevance
Conclusion
Similarities/differences Unexpected/negative results Limitations (validity, reliability)
Implications
Previous studies
Current study
Future studies
Specific
General
How do you advance your field?
Manuscripts with impact Conclusion
In conclusion, we found an independent, graded association between lower levels of the estimated GFR and the risks of death, cardiovascular events, and hospitalization. These risks were evident at an estimated GFR of less than 60 ml per minute per 1.73 m2 and substantially increased with an estimated GFR of less than 45 ml per minute per 1.73 m2. Our findings support the validity of the National Kidney Foundation staging system for chronic kidney disease but suggest that the system could be further refined, since all persons with stage 3 chronic kidney disease (GFR, 30 to 59 ml per minute per 1.73 m2) may not be at equal risk for each outcome. Our findings highlight the clinical and public health importance of chronic kidney disease that does not necessitate dialysis.
Conclusion
Key finding
Implications
Future directions
Importance
Go et al. N Engl J Med. 2004; 351: 1296–1305.
Why is your study important?
Manuscripts with impact Link your ideas
General background
Aims
Methodology
Results and figures
Summary of findings
Implications for the field
Relevance of findings
Problem in the field
Current state of the field Introduction
Methods
Results
Discussion
Solution
Situation/Problem
Evaluation/Comment
Activity 2
Please see Activity 2 in your workbook
Section 3
Making the best first impression
Customer Service Marketing your work Title and abstract
First impression of paper: clear/concise/convincing
Importance of your results
Validity of your conclusions
Relevance of your aims
It sells your work: Readers judge your style & credibility
Often first/only part that is read by
readers & reviewers
Your title & abstract summarize your study
Customer Service Marketing your work Title and abstract
Title
Important points
Only the main idea Accurate, simple Population/model Include keywords Fewer than 20 words Hanging title:
method/study type
Avoid
Unneeded words (a/the, A study of) Complex or sensational words Complex word order Abbreviations “New” or “novel”
Customer Service Marketing your work Title and abstract
Interrogative Can ischemic preconditioning
improve prognosis after coronary artery bypass surgery?
Indicative/ Descriptive*
Prognostic effects of ischemic preconditioning in coronary artery
bypass patients
* + Method (subtitle)
Xxxxxxx: randomized controlled trial
Assertive/ Declarative*
Ischemic preconditioning improves prognosis after coronary artery
bypass / Improved prognosis after coronary artery bypass by ischemic
preconditioning
Title
Customer Service Marketing your work Title and abstract
Search Engine Optimization
Identify 7–8 keywords (include synonyms, use Medical Subject Headings [MeSH]*)
Use 2 in your title, 5–6 in the keyword list
Use 3 keywords 3–4 times in your abstract
Use keywords in headings when appropriate
Be consistent throughout your paper
Cite your previous publications when relevant
*Or standard terms from PsycINFO, BIOSIS, ChemWeb, ERIC Thesaurus, GeoRef, etc
Customer Service Marketing your work Title and abstract
Context Background, problem, aim
Results Outcomes, effects,
properties, statistics
Conclusion Relevance, implications Learning points, future
Methods Patients/materials/animals Treatments, measurements
No references, unusual abbreviations, figures/tables Clinical: funding & trial registration number after abstract
Abstract
Customer Service Marketing your work Unstructured abstract
Modified from: Cannegieter et al. Blood. 2015; 125: 229‒235.
Numerous systemic treatment options exist for patients with mycosis fungoides (MF) and Sézary syndrome (SS); however, the comparative efficacy of these treatments is unclear. We performed a retrospective analysis of our cutaneous lymphoma database to evaluate the treatment efficacy of 198 MF/SS patients undergoing systemic therapies. The primary end point was time to next treatment (TTNT). Patients with advanced-stage disease made up 53%. The median follow-up time from diagnosis for all alive patients was 4.9 years (range 0.3‒39.6), with a median survival of 11.4 years. Patients received a median of 3 lines of therapy (range 1‒13), resulting in 709 treatment episodes. Twenty-eight treatment modalities were analyzed. We found that the median TTNT for single- or multiagent chemotherapy was only 3.9 months (95% confidence interval [CI] 3.2‒5.1), with few durable remissions. α-interferon gave a median TTNT of 8.7 months (95% CI 6.0-18.0), and histone deacetylase inhibitors (HDACi) gave a median TTNT of 4.5 months (95% CI 4.0‒6.1). When compared directly with chemotherapy, interferon and HDACi both had greater TTNT (P < .00001 and P = .01, respectively). In conclusion, this study confirms that all chemotherapy regimens assessed have very modest efficacy; we recommend their use be restricted until other options are exhausted.
Customer Service Marketing your work
Modified from: Cannegieter et al. Blood. 2015; 125: 229‒235.
Numerous systemic treatment options exist for patients with mycosis fungoides (MF) and Sézary syndrome (SS); however, the comparative efficacy of these treatments is unclear. We performed a retrospective analysis of our cutaneous lymphoma database to evaluate the treatment efficacy of 198 MF/SS patients undergoing systemic therapies. The primary end point was time to next treatment (TTNT). Patients with advanced-stage disease made up 53%. The median follow-up time from diagnosis for all alive patients was 4.9 years (range 0.3‒39.6), with a median survival of 11.4 years. Patients received a median of 3 lines of therapy (range 1‒13), resulting in 709 treatment episodes. Twenty-eight treatment modalities were analyzed. We found that the median TTNT for single- or multiagent chemotherapy was only 3.9 months (95% confidence interval [CI] 3.2‒5.1), with few durable remissions. α-interferon gave a median TTNT of 8.7 months (95% CI 6.0‒18.0), and histone deacetylase inhibitors (HDACi) gave a median TTNT of 4.5 months (95% CI 4.0‒6.1). When compared directly with chemotherapy, interferon and HDACi both had greater TTNT (P < .00001 and P = .01, respectively). In conclusion, this study confirms that all chemotherapy regimens assessed have very modest efficacy; we recommend their use be restricted until other options are exhausted. How does your study contribute to your field?
What did you find?
What did you do?
Why did you do the study?
Unstructured abstract
Customer Service Marketing your work
Dear Dr Lippman,
Please find enclosed our manuscript entitled “Evaluation of the Glasgow prognostic score in patients undergoing curative
resection for breast cancer liver metastases,” which we would like to submit for publication as an Original Article in the Breast
Cancer Research and Treatment.
The Glasgow prognostic score (GPS) is of value for a variety of tumours. Several studies have investigated the prognostic value of the GPS in patients with metastatic breast cancer, but few studies have performed such an investigation for patients undergoing liver resection for liver metastases. Furthermore, there are currently no studies that have examined the prognostic value of the modified GPS (mGPS) in these patients. The present study evaluated the mGPS in terms of its prognostic value for postoperative death in patients undergoing liver resection for breast cancer liver metastases.
A total of 318 patients with breast cancer liver metastases who underwent hepatectomy over a 15-year period were included in this study. The mGPS was calculated based on the levels of C-reactive protein and albumin, and the disease-free survival and cancer-specific survival rates were evaluated in relation to the mGPS. Prognostic significance was retrospectively analyzed by univariate and multivariate analyses. Overall, the results showed a significant association between cancer-specific survival and the mGPS and carcinoembryonic antigen level, and a higher mGPS was associated with increased aggressiveness of liver recurrence and poorer survival in these patients. This study is the first to demonstrate that the preoperative mGPS, a simple clinical tool, is a useful prognostic factor for postoperative survival in patients undergoing curative resection for breast cancer liver metastases. This information is immediately clinically applicable for oncologists treating such patients. As a premier journal covering the broad field of cancer, we believe that the Breast Cancer Research and Treatment is the perfect platform from which to share our results with the international medical community.
Give the background to the research
What was done and what was found
Interest to journal’s readers
Cover letter to the editor
Editor’s name Manuscript title
Article type
Ethics Declarations, Recommended reviewers, Author’s contact information
Customer Service Marketing your work
Recommending reviewers
Where to find them?
From your reading/references, networking at conferences
How senior? Aim for mid-level researchers
Who to avoid? Collaborators (past 5 years),
researchers from your university
International list: 1 or 2 from Asia, 1 or 2 from Europe, and 1 or 2 from North America
Choose reviewers who have published in your target journal
Customer Service Marketing your work Cover letter to the editor
We confirm that this manuscript has not been published elsewhere and is not under consideration by another journal. All authors have approved the manuscript and agree with submission to the Breast Cancer Research and Treatment. This study was funded by the Japanese Ministry of Health, Labour and Welfare. The authors have no conflicts of interest to declare.
Declarations related to publication ethics Source of funding Conflicts of interest
Ethics
Funding
Conflicts of interest
Customer Service Marketing your work Cover letter to the editor
This study is the first to demonstrate that the preoperative mGPS, a simple clinical tool, is a useful prognostic factor for postoperative survival in breast cancer patients undergoing curative resection for liver metastases. This information is immediately clinically applicable for surgeons and medical oncologists treating such patients. As a premier journal covering breast cancer treatment, we believe that Breast Cancer Research and Treatment is the perfect platform from which to share our results with all those concerned with breast cancer.
Why interesting to the journal’s readership (para 4)
Target your journal – keywords from the Aims and Scope
Relevance
Conclusion/importance
Section 4
Avoiding common peer reviewer complaints
Reviewer complaints
What reviewers are looking for
The science
The manuscript
Relevant hypothesis Good experimental design Appropriate methodology Good data analysis Valid conclusions
Logical flow of information Manuscript structure and formatting Appropriate references High readability
Reviewer complaints
Common complaints – Introduction
Ideas are not logically organized
Important topics in the Introduction are not mentioned again in the Results/Discussion
Important topics in the Results/Discussion are not mentioned in the Introduction
Cited studies are not up-to-date
Cited studies are geographically biased
Why study needs to be done?
Keep focused
Write last
<5 years
International
Reviewer complaints
Common complaints – Methods
Transparency in study design
Sample size not large enough (no power calculation)
Patient enrollment, exclusion, & randomization unclear
Interventions and assessments not clearly described
Unclear how missing data (lost to follow-up) were handled
Ethical approval and informed consent (x2 ) not clear
Consult a statistician
Use flowchart
Reproducibility
Imputation methods
Always required
Reviewer complaints
Statistical significance does not equal clinical significance!
“When possible, quantify findings and present them with appropriate indicators of measurement error or uncertainty (such as confidence intervals).”
http://www.icmje.org/recommendations/browse/manuscript-preparation/preparing-for-submission.html
“Avoid relying solely on statistical hypothesis testing, such as P values, which fail to convey important information about effect size and precision of estimates.”
Common complaints – Results
Reviewer complaints
“Drug A significantly reduced LDL cholesterol by 28% (p<0.05). Therefore, Drug A is effective in reducing cholesterol levels…”
• How much is 28%? Is this clinically relevant? • How does this effect generalize to the population? What is
the 95% CI?
Common complaints – Results
Statistical significance does not equal clinical significance!
Reviewer complaints
“Drug A significantly reduced LDL cholesterol levels from 4.7±0.3 mmol/L to 3.4±0.6 mmol/L (p=0.02, 95% CI: 0.8–1.8). Because a minimal reduction of 1.4 mmol/L is required to be clinically effective, the efficacy of Drug A is still unclear.”
• Use absolute values • State exact P-value • State 95% CI and minimal clinically relevant difference
Common complaints – Results
Reviewer complaints
Patient parameters …improved significantly; it is significant that… X was correlated with Y The risk of developing X in this case-control study…
Patient variables …improved considerably/markedly; it is important that… X was associated with/related to/linked to Y The odds of developing X in this case-control study…
Don’t misuse statistical words!
Common complaints – Results
Reviewer complaints
Unexpected/negative results not explained
Limitations not discussed
The results are repeated in the Discussion
Conclusions are overgeneralizedons are overgeneralized
Reporting transparency
Establish credibility
Summarize/interpret results
Common complaints – Discussion
Based on presented findings
Section 5
Succeeding with Edanz
Succeeding with Edanz
S
Overview
• エダンズのご紹介
• 英文校正・投稿注力サービス
• 近畿大学医学部様向け特別ご提案
• まとめ
北 麻美子
エダンズ グループ ジャパン 法人チーム セールスマネジャー
Succeeding with Edanz エダンズの紹介
国際ジャーナルでの 論文採用率を高めます
150,000
80
Succeeding with Edanz エダンズの紹介
BioMed Central社の白書より(2014年11月)
Succeeding with Edanz
S
エディターの条件
母国語が英語
研究経験
出版実績
専門分野に関する深い知識
高い校正能力と言語能力
エダンズの専門家
Succeeding with Edanz
S
Daniel Wheeler 2009 - DM Critical Care and Anaesthesiology, University of Oxford 2006 - PhD Neurobiology, University of Cambridge 1994 - BM BCh Clinical Medicine, University of Oxford • Lecturer and honorary consultant anesthetist at the University of Cambridge • Member of the Royal College of Physicians since 1997 • Published over 40 peer-reviewed papers
Ludovic Croxford 2000 - PhD Medical Immunology, University College London 1994 - BSc Biochemistry and Toxicology, University of Surrey • Multi-disciplinary immunologist with research experience in a wide
range of fields, especially neuroimmunology, autoimmunity and oncology
• Published over 40 peer-reviewed papers, reviews and book chapters in journals including Nature, Nature Immunology and Nature Medicine
エダンズの専門家
Succeeding with Edanz
S
近畿大学医学部様への 研究サポート
近畿大学医学系研究者から発信される国際 論文の質と量を高める
論文出版までの全プロセスにおけるサポート
エダンズの高品質サービスを、簡単に、お得な 価格でご提供
Succeeding with Edanz
S
1. 英文校正サービス • 英文校正 • 2回目の校正 • 再校正 • Point-by-Point チェック +校正
エダンズのサービス
2. 投稿注力サービス • 目標ジャーナルの選択
• 事前査読
• カバーレターの作成
• 査読者の推薦
• アブストラクトの作成
• カスタムサービス (e.g., リライティング, リフォーマッティング)
Succeeding with Edanz
S 採用!
エダンズのサービス
Succeeding with Edanz
S
1. 英文校正
英文校正:
誤った文法を訂正し、科学的な表現の明確性、適切性を高める 研究の新規性、有用性をより明確にする 目標ジャーナルの投稿規定に沿っているかを確認し、異なる場合はコメントを残す
2回の校正で、著者とエディターの認識を揃え明確性を高める
エダンズのサービス
Succeeding with Edanz
S
1. 英文校正
再校正:
査読後に修正した原稿に対する英文校正
Point-by-Pointチェック+校正:
査読後の原稿修正および回答レターのドラフトに対するサービス
論文の修正内容と回答レターの内容が一致しているか、また査読者の各コメントに対応しているかを確認
回答レターおよび修正原稿の英文校正
エダンズのサービス
Succeeding with Edanz
S
2. 投稿注力サービス
事前査読:
投稿前に、専門家がプレ査読を行い、研究の内容にまで踏み込み原稿を批判的に精査する
目標ジャーナル投稿前に、論文の質をさらに高めるアドバイスを得る
リジェクトされた原稿に関して、修正のためのアドバイスを得る
エダンズのサービス
Succeeding with Edanz
S
2. 投稿注力サービス
カバーレターの作成:
研究の有用性・新規性を説明した、説得力のあるカバーレターを作成する
査読者の推薦: 論文に好意的なふさわしい査読者を4名まで選出
エダンズのサービス
Succeeding with Edanz
近畿大学医学部専用 ご依頼プラットフォーム
edanzediting.co.jp/kinki_medicine/
Succeeding with Edanz
• 全サービス10%割引
• クリニシャン・投稿サポートパッケージ ①英文校正 ②事前査読
③査読者の推薦 ④カバーレターの作成 各1回ずつご利用可 99,000円(税別・通常価格の15%割引)
近畿大学医学部様 特別ご提案
必ず専用ご依頼プラットフォームからお申込みください。 作業完了後の請求はすべて(株)近大アシストから行われますの
で、近大アシストにお支払ください。
Succeeding with Edanz 学術セミナー・ ワークショップ
インタラクティブ性を重視 カスタマイズが可能 経験を積んだ講師陣
セミナー開催実績ご紹介 : www.edanzediting.co.jp/past_events
【主なトピック】 論文執筆・ジャーナル投稿 プレゼンテーション・スキル 論文読解法 研究倫理 論文プロモーション など
Researchers face challenges on the path to publication success
Preparation
Journal Selection
Writing
Submission
Peer Review
Publication Success
• Read/manage references
• Write outline • Authorship • Peer feedback • Present at
conferences
• Assess research impact
• Compare journals/ publishers
• (Pre-) Submission strategy
• Write/edit in English without plagiarism
• Writing process • Title & Abstract • Follow journal
& reporting guidelines
• Publication ethics
• Display items, supplemental material
• Ethics declarations
• Cover letter • Select reviewers • Navigate
submission systems
• Navigate review process
• Understand editor & reviewers
• Revise paper • Respond to
reviewers, point by point
• Resubmit or submit elsewhere
• Archive/share • Promote work
to (non)-academic community
• Next project/ budget/grant
• Collaborators • Track citations
and altmetrics • Patenting • Update CV
Edanz supports researchers throughout their career
Preparation
Journal Selection
Writing
Submission
Peer Review
Publication Success
• Training in reading papers, ethics, writing, presenting
• Expert Scientific Review
• Expert Scientific Review
• Journal Selection & submission strategy
• Training in ethics, writing, presenting
• Editing • Reformatting • Abstract
Development • Guided
rewriting
• Training in ethics, writing, presenting
• Editing • Cover Letter
Development • Reviewer Rec-
ommendation
• Training in navigating peer review
• Review Editing • Point-by-point
checking • Response
Letter Development
• Reformatting
• Press release, news writing
• Media training
• Training for early career researchers
• Training in writing grant proposals
• Grant proposal editing
S
Be an effective communicator
Your goal is not only to be published, but also to be widely read and cited
Developing advanced writing skills
Logically communicating your ideas in your manuscript
Making the best first impression
Avoiding common peer reviewer complaints
Succeeding with Edanz
Thank you!
Any questions?
Follow us on Twitter
@EdanzEditing
近畿大学医学部・大学院医学研究科専用 ご依頼プラットフォーム
edanzediting.co.jp/kinki_medicine/
Download and further reading edanzediting.co.jp/kinki1511
Trevor Lane: [email protected] Eri Kinoshita: [email protected]
Mamiko Kita: [email protected]
Like us on Facebook
facebook.com/EdanzEditing